Taxation on Sugary Drinks and Consumption Reduction: Evidence from Mexico
Mexico's taxation on sugary drinks has effectively reduced consumption, highlighting the potential of health taxes as a public health strategy to deter unhealthy behaviors and combat the obesity epidemic, supporting broader implementation of similar interventions globally.
December 2020
COVID-19 Pneumonia: Tailoring Treatments to Phenotypic Variability
COVID-19 pneumonia manifests with diverse clinical phenotypes, ranging from asymptomatic hypoxemia to severe dyspnea, necessitating individualized treatment approaches based on disease severity and patient characteristics to optimize therapeutic outcomes.
December 2020
COVID-19: Protecting Hospitals from Nosocomial Transmissions
Delayed diagnoses contribute to nosocomial transmissions in hospitals, emphasizing the need for improved diagnostic protocols and infection control measures to protect healthcare facilities from the invisible threat of COVID-19.
December 2020
Persistence of SARS-CoV-2 Virus in Aerosols and on Surfaces: Implications for Transmission
Examination of the persistence rates of SARS-CoV-2 in aerosols and on surfaces compared to SARS-CoV-1, shedding light on the potential routes of transmission and informing infection control measures.
December 2020
Evaluation of Non-Pharmacological Interventions against COVID-19 and Influenza: Impact Assessment
Non-pharmaceutical interventions, including border restrictions, quarantine, isolation, distancing measures, and behavioral changes, demonstrate effectiveness in reducing transmission of COVID-19 and influenza, highlighting the importance of comprehensive public health strategies to mitigate infectious disease spread.
December 2020
Treatment Guidelines for Patients with COVID-19 Infection: Evidence-Based Recommendations
The Infectious Diseases Society of America (IDSA) develops updated treatment guidelines based on emerging evidence to support healthcare professionals in managing COVID-19 patients, providing evidence-based recommendations for patient care and clinical decision-making.
November 2020
COVID-19: Treatment Strategies for Severe Acute Respiratory Distress Syndrome
Authors propose pragmatic approaches to administering extracorporeal membrane oxygenation (ECMO) to patients with severe COVID-19-related respiratory failure, aiming to optimize outcomes in critically ill individuals.
November 2020
CDC Recommendations for Pharmacies During the COVID-19 Pandemic: Minimizing Risks for Staff and Customers
The CDC provides guidance applicable to all pharmacy staff to mitigate their exposure to SARS-CoV-2 and reduce transmission risks to customers, emphasizing the importance of implementing infection control measures and promoting adherence to public health recommendations.
November 2020
Clinical Characteristics of Children with Coronavirus Disease 2019 (COVID-19)
Analysis of a large cohort of children with COVID-19 reveals milder clinical manifestations compared to adults, with infants and young children being particularly susceptible to infection despite less severe symptoms.
November 2020
Radiological Findings of 81 Patients with COVID-19 Pneumonia in Wuhan: Evolution of Chest CT Imaging Features
Analysis of chest CT imaging features in COVID-19 pneumonia patients from Wuhan sheds light on the evolution of radiological findings throughout the course of the disease, offering insights into disease progression and potential prognostic indicators.
November 2020
